Adverse Outcomes and Predictors of Underuse of Antithrombotic Therapy in Medicare Beneficiaries With Chronic Atrial Fibrillation

F. Gage, Brian; Boechler, Michael; L. Doggette, Amy; Fortune, Gary; C. Flaker, Greg; W. Rich, Michael; J. Radford, Martha

doi:10.1161/01.str.31.4.822

Public

Adverse Outcomes and Predictors of Underuse of Antithrombotic Therapy in Medicare Beneficiaries With Chronic Atrial Fibrillation

Published in Stroke • Apr 1, 2000

Authors:

Brian F. Gage

Michael Boechler

Amy L. Doggette

Abstract

BACKGROUND AND PURPOSE: Antithrombotic therapy can prevent strokes and transient ischemic attacks (TIAs) in carefully selected patients who have chronic nonvalvular atrial fibrillation (NVAF). Our objectives were 3-fold: to document the use of warfarin and aspirin therapy in Missouri Medicare benefi...

Subject

Medicine

Warfarin

Antithrombotic

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!